background and objectives: the appearance of antibiotic resistance in streptococcus pneumoniae has raised a global concern over the past three decades. this study was conducted to determine the antimicrobial susceptibility of s. pneumoniae isolated from patients in children´s medical center (cmc) hospital during 2001 to 2011. materials and methods: during the 11 years period, a total of 194 s. ...

conclusions a slightly higher mortality in patients with pneumonia, caused by s. maltophilia, was strived to explain by advanced age, higher acute physiology and chronic health evaluation (apache ii) and sepsis related organ failure assessment (sofa) score, and also higher inappropriate antibiotic use. results a total of 71 patients with s. maltophilia nosocomial infections, 35 (49.3%) primary ...

Patients with nosocomial pneumonia caused by Stenotrophomonas maltophilia often receive inadequate empiric antibiotic therapy, potentially increasing mortality. Knowledge of the risk factors associated with S. maltophilia pneumonia may better guide the selection of empiric antibiotic therapy. Potential risk factors for S. maltophilia pneumonia were retrospectively analyzed for critically ill tr...

Background: Identifying regional types and evaluating the frequency of pneumococcal strains has become increasingly important especially in vaccination. The purpose of this study was the identification and frequency determination of our regional serotype and evaluation of the performance of recent type specific multiplex PCR for the diagnosis of streptococcus pneumonia serotypes. Methods: All ...

background: identifying regional types and evaluating the frequency of pneumococcal strains has become increasingly important especially in vaccination. the purpose of this study was the identification and frequency determination of our regional serotype and evaluation of the performance of recent type specific multiplex pcr for the diagnosis of streptococcus pneumonia serotypes. methods: all i...

REFERENCES 1 Krüger S, Ewig S, Marre R, et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 2008; 31: 349–355. 2 Schuetz P, Suter-Widmer I, Chaudri A, et al. Prognostic value of procalcitonin in community-acquired pneumonia. Eur Respir J 2011; 37: 384–392. 3 Krüger S, Ewig S, Kunde J, et al. Assessment of inflamma...

Development and validation of a clinical prediction rule for hospitalization due to pneumonia or influenza or death during influenza epidemics among community-dwelling elderly persons. J Infect Dis 2004; 189: 450–458. 4 Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2...